This can be explained by the different molecular subtype found in these regions, showing a triple negative breast cancer (TNBC) and human epidermal growth factor receptor 2 (HER2) enriched predominance compared to the Luminal B subtype predominance found in the current study. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.